PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
🔒 Subscribers only
AUTH/2087/1/08
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Flynn Pharma
Flynn Pharma sent a “Dear Doctor” letter (18 November 2007) to approximately 3,000 paediatricians and 800 child psychiatrists, headed “Shortage of methylphenidate immediate release tablets”…
Clauses: NONE
🔒 Subscribers only
AUTH/2085/1/08
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
MSD/Schering-Plough Ezetrol insert in The Pharmaceutical Journal
A pharmacist’s letter in The Pharmaceutical Journal criticised a four-page promotional insert for Ezetrol (ezetimibe), jointly sponsored by Merck Sharp & Dohme and Schering-Plough.The insert,…
Clauses: NONE
🔒 Subscribers only
AUTH/2084/1/08
HCP Hospitality & Meetings Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis
An anonymous, non-contactable complainant alleged excessive hospitality and inappropriate representative conduct at a Novartis-sponsored meeting held at a restaurant in January 2008.Allegations inc…
Clauses: NONE
🔒 Subscribers only
AUTH/2083/1/08
Data & Publications Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Roche breached Clause 9.9 after GP received unsolicited promotional email about Tamiflu via an agenc
A general practitioner (GP) received an unsolicited email about Tamiflu (oseltamivir) to their NHS email address.The email was sent by Roche Products Limited via a third-party agency.The GP said th…
Clauses: 9.9
🔒 Subscribers only
AUTH/2111/3/08
Transfers of Value Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Gamble Pharmaceuticals UK
What happened A general practitioner complained about an email received in March 2008 relating to Actonel Combi (risedronate sodium tablets plus calcium and vitamin D effervescent granules). Actone…
Clauses: NONE
🔒 Subscribers only
AUTH/2159/8/08
Transfers of Value Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Otsuka Pharmaceuticals
What happened Anonymous complainants alleged Bristol-Myers Squibb provided inappropriate hospitality at a two-day meeting for psychiatrists, including food, hotels and an alleged cultural programme…
Clauses: NONE
🔒 Subscribers only
AUTH/2079/1/08
Transfers of Value Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Gamble Pharmaceuticals UK
What happened Roche Products Limited and GlaxoSmithKline UK Ltd complained about an Actonel (risedronate) exhibition panel (ref ACT3664) used by Sanofi-Aventis and Procter & Gamble Pharmace…
Clauses: NONE
🔒 Subscribers only
AUTH/2102/2/08
Transfers of Value Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Meda Pharmaceuticals
What happened An anonymous company representative complained about Meda Pharmaceuticals Limited’s promotion of Aldara (imiquimod cream) and the activities of its representatives. Concerns include…
Clauses: 15.9,3.2
🔒 Subscribers only
AUTH/2149/7/08
Promotional Material Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Syner-Med
What happened A freelance medical writer complained about promotional material for Ferinject (ferric carboxymaltose) distributed by Syner-Med (Pharmaceutical Products) Limited at the British Renal …
Clauses: NONE
🔒 Subscribers only
AUTH/2428/8/11
Scientific Information Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca
What happened Two complaints from members of the public challenged a full-page Onglyza (saxagliptin) advertorial placed in the Health Service Journal (HSJ) (published 4 August 2011). Concerns were …
Clauses: 11.1
🔒 Subscribers only
AUTH/2036/8/07
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Procter & Gamble
Procter & Gamble (P&G) voluntarily admitted that an Intrinsa (testosterone transdermal patch) advertisement appeared in the June 2007 edition of the journal Wellbeing (ref INT-UK3063).P&…
🔒 Subscribers only
AUTH/2034/8/07
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Recordati
The MHRA passed to the PMCPA a complaint it had received from a hospital pharmacy manager about a ‘Dear Dispensary Manager’ letter for Tradorec XL (prolonged release tramadol) dated 29 June 200…
Clauses: NONE
🔒 Subscribers only
AUTH/2035/8/07
Off-label Promotion Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Leo Pharmaceuticals
A consultant dermatologist complained about a Leo Pharma letter (ref 1008/10488) dated 26 June 2007 promoting Dovobet (calcipotriol/betamethasone) and referring to discontinuation of Dovonex Ointme…
Clauses: NONE
🔒 Subscribers only
AUTH/2032/8/07
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Novartis
Bristol-Myers Squibb (BMS) complained that Novartis’ ENACT (Expanding Nilotinib Access Clinical Trial) expanded access programme for investigational nilotinib amounted to disguised promotion of a…
Clauses: NONE
🔒 Subscribers only
AUTH/2031/8/07
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
AstraZeneca
A hospital NHS Trust formulary manager complained about an AstraZeneca representative’s conduct promoting Crestor (rosuvastatin).Crestor had been rejected by the Trust’s Drug & Therapeutics…
Clauses: NONE
🔒 Subscribers only
AUTH/2071/11/07
Data & Publications Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Takeda UK Limited — Competact (pioglitazone and metformin); Actos (pioglitazone)
A general practitioner complained about a Takeda UK Limited promotional leavepiece (ref AC070946) for Competact (pioglitazone and metformin) and Actos (pioglitazone).The complaint alleged that data…
Clauses: 7.2
🔒 Subscribers only
AUTH/2029/7/07
HCP Hospitality & Meetings Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Sanofi-Aventis & Bristol-Myers Squibb
The Myocardial Infarction National Audit Project (MINAP) complained about a series of meetings sponsored by Sanofi-Aventis and Bristol-Myers Squibb, focusing on one meeting invitation for “Gettin…
Clauses: NONE
🔒 Subscribers only
AUTH/2060/10/07
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Teva UK Ltd — Qvar; Clenil Modulite
A general practitioner complained about an insert distributed with the September 2007 issue of Guidelines in Practice, titled “Making an informed choice. A guide to changing to CFC-free beclometa…
Clauses: 7.2,7.4,9.5,18.4
🔒 Subscribers only
AUTH/2028/7/07
Patient Organisations Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi
Novo Nordisk complained about Sanofi-Aventis promotional materials for Lantus (insulin glargine) claiming “24 hour glycaemic control” / “Once daily 24-hour glycaemic control” and patient-fa…
Clauses: NONE
🔒 Subscribers only
AUTH/2058/10/07
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Pfizer Limited — Champix (varenicline)
A primary care trust chief pharmacist complained about an advertisement for Champix (varenicline) placed by Pfizer Limited in the Health Service Journal (HSJ) on 11 October 2007 (ref CHA055a).The c…
Clauses: 12.1,20.1
🔒 Subscribers only
AUTH/2027/7/07
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
GlaxoSmithKline
A member of the public alleged a close friend was hospitalised after overdosing on medicines allegedly purchased privately from a GlaxoSmithKline (GSK) representative.The complainant alleged unethi…
Clauses: NONE
🔒 Subscribers only
AUTH/2026/7/07
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Boehringer Ingelheim
A hospital consultant complained about an Actilyse (alteplase) press release placed on Boehringer Ingelheim’s corporate website by German corporate colleagues.The press release related to a UK NI…
Clauses: NONE
🔒 Subscribers only
AUTH/2025/7/07
Patient Organisations Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Napp
A GP complained after the duty manager of an old people’s home/care home asked her to prescribe BuTrans (buprenorphine transdermal patches).The GP alleged a Napp representative had visited the ho…
Clauses: NONE
🔒 Subscribers only
AUTH/2023/7/07
HCP Hospitality & Meetings Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Pfizer
A teaching PCT pharmacist complained about a Pfizer Champix (varenicline) GP referral aid (a pad of tear-off letters) used by smoking cessation service providers (including community pharmacists an…
Clauses: 9.1,9.2
← Prev 61 62 63 64 65 66 67 Next → Page 64 of 73 — 1752 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews